Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...
Hosted on MSN
Kimberly-Clark Sees 14% Watchlist Spike On Stocktwits After ‘Gutsy’ Kenvue Deal: Retail Optimistic
・Stocktwits watchers for Kimberly-Clark are up 14% over the last week, just after the company announced its $48.7 billion deal to buy Kenvue. ・The massive deal has investors concerned, in part due to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results